Care Products For Skin Care – Tips on Searching Should Start With Skin Care Natural Products

Contrary to what most people think, aging skin is a problem that can be easily taken care of if you use the right anti aging treatment products. The only thing you should be aware of is finding the best products can be a little tricky if you do not have a basic idea of what is good and what is bad for your skin. So, let us take a look at (skin) care care product and how you can choose these products for your skin.In order to find out the best products aging reversal, you should first find out which is the best anti aging skin treatment available today. Actually, finding that is not as hard as you think it is. Just go by the basic thumb rule when it comes to skin care – anything natural is only good for your skin. So, natural skin care, or organic skin care as it is popularly called, is obviously better than artificial skin care. Let us see why it is so.There are two important things you should consider when you are looking for the best anti aging skin treatment. First, it should be really effective. Second, it should be very safe. Going by these two conditions, one can safely assume that organic skin care is indeed the best way to take care of your skin.Artificial cosmetic products are full of chemicals that are bad for your health. And when I say ‘bad for your health’, I don’t just mean skin rashes or allergic reactions, but serious health problems in your internal organs. If you find chemicals like alcohols, phenol carbolic acid, parabens, triclosans, liquid paraffin, and artificial fragrance in a skin care product, do not buy it. These chemicals are commonly found in artificial cosmetic products and they can cause serious health problems like allergic reactions, anemia, depression, renal failure, stroke, and cancer. This is the reason why organic skin care is considered the best anti aging skin treatment.Organic skin care products do not contain any of these harmful chemicals. They are full of natural ingredients which are very safe to use. No matter what your skin type is, you can use organic skin creams as there are no health risks associated with using them. This is why they are considered the best anti aging skin care treatment products.Recently, a lot of skin care experts have been talking about some organic ingredients which are considered the best at treating skin care problems today. They include seaweed extract, manuka honey, CynergyTK, and special forms of CoQ10. All these ingredients are very rare and extremely effective. They can reverse the aging process, repair your damaged skin, get rid of all the skin problems, and improve your skin condition tremendously. Most importantly, they are completely safe to use. So, if you are looking for the best anti aging skin care treatment products, look for the ones with these ingredients.Now you know two important things about skin care – which is the best anti aging skin treatment and how to find the best anti aging skin care products. All you need to do now is get yourself a bunch of good organic skin creams, cleansers, and night creams and use them regularly. You will be surprised to see the results.

S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).

X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.

Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.

Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.

Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.

Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.

Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.

Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.

Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.

The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.

In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.

In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.

Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.

Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.

The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.

Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.

The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).

In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.

S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?

Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.

Cardinal Health stock’s relative strength line has also been trending up for months.

The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.

Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.

Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.

Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.

Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.

Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.

Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.

The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.

How Millett Grew Steel Dynamics From A Three Employee Business

STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.

Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.

GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.

The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.

On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.

Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.

During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.

Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.

IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.

How to Make Money Investing in Stocks in Any Market

I write this with one eye on 2015 and 2016; and the other focused on how to make money investing in stocks. And I remind myself that there are two market concepts that must be understood and considered in order to make money investing in stocks in any market.Nobody can always make money investing in stocks (also called equities), but those who outperform year after year do so by applying two basic concepts. Here we will use 2015 and 2016 as an example because they promise to be challenging years. We’re not talking about finding tomorrow’s glamour stocks or short-term trading here. We’re talking about two important and basic market concepts that many investors either are not aware of, or that they overlook at their own expense.Concept #1 refers to the cyclical nature of markets. Prices will always fluctuate, but there are reoccurring and identifiable price trends that can either make you or break you. A trend of rising prices is called a “bull market”, and just about anybody can make money investing in stocks in these “good” markets. The good news is that they often last for several years. The bad news is that they are always followed (sooner or later) by a trend of falling prices which is called a “bear market’, or simply a “bad” market for most investors.The good news is that bear markets (like the last two) sometimes last for less than two years. The bad news is that they can be swift and brutal – creating losses of 50% or more for investors (like in the last two bear markets). The other bad news is that very few investors ever make money investing in stocks in a bear market. More bad news: if you lose half your money in a bad market, you then need to double your money in the next good market in order to simply break even.As I look forward to 2015 and 2016, I also look back to the years 2000 and 2007. Both years were the beginning of bear markets that followed good markets. Both created 50% losses in less than two years and wiped out most of the profits investors earned in the preceding good markets. As of 2015, the current bull market that started in early 2009 is almost six years old. The stock market has again hit all-time highs. The challenge now is how to make money investing in stocks in 2015 and beyond if a new bear market hits in 2015 or 2016.As we move on to concept #2, note that we are not talking about how to avoid losses in a bear market, but how to actually make money investing in stocks. You can always avoid losses by getting out while you are ahead, or you can reduce losses by cutting your asset allocation to stocks.While just about everyone knows that you can make money investing in stocks when you buy them and equities prices rise… most folks do not know that you can also bet that prices will fall and make money if they do. This is called taking a “short” position. It’s legal, and has been going on for many years. During the Great Depression some people in the know got filthy rich “going short”; and during the financial crisis of 2007- 2008 you could have made big bucks betting against the market as well.This is concept #2 and is the flip side of how markets work. The good news is that it will be easier than ever to make this bet in 2015 and 2016. The bad news is that it’s not for everyone, because you can take significant losses if you go here and prices move UP, against you. Actually, I’ve known people who are repulsed by the concept and some who even think that it’s un-American and should be illegal. That having been said, it’s a fact of life and part of the free-market system we live in.It’s never easy to make money investing in stocks by going “short” because the market trend over the long term has been up. On the other hand, when the market goes south you won’t make money investing in stocks any other way. You’ll lose it along with about 98% of investors. The easiest way to short the market these days is to simply buy stocks called INVERSE EXCHANGE TRADED FUNDS (ETFs). Popular examples (stock symbols) include DXD, SDS, and QID. In order, these allow you to short the three major indexes: the Dow, the S&P 500, and the NASDAQ.These (and other) inverse ETFs are designed to go UP in price when the market indexes go DOWN. In fact, if the index goes down 1% they are designed to go up 2%. If you want to try to make money investing in stocks in a bad market, inverse ETFs are the simplest way to do it. They can be easily bought and sold through a discount broker for about $10 per trade.Above all else, keep the concept of bull and bear markets in mind in your endeavor to make money investing in stocks in 2015, 2016 and well beyond. While a rising tide lifts all boats, a falling tide can leave them dead in the water. If you are adventuresome and can handle the risk, you now know how to make money investing in stocks when the tide goes out.